# Similarities and Differences of Biological Therapies for Severe Asthma.

> **NCT04665141** · — · UNKNOWN · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 600 (estimated)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** Mepolizumab
- **BIOLOGICAL:** Omalizumab
- **BIOLOGICAL:** Reslizumab
- **BIOLOGICAL:** Benralizumab
- **BIOLOGICAL:** Dupilumab

## Key facts

- **NCT ID:** NCT04665141
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-07
- **Primary completion:** 2022-11
- **Final completion:** 2022-11
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2021-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04665141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04665141, "Similarities and Differences of Biological Therapies for Severe Asthma.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04665141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*